BR0014831A - Droga terapêutica para lesões refratárias, compreendendo uma substância com atividade inibidora de elastase leucocitária humana - Google Patents

Droga terapêutica para lesões refratárias, compreendendo uma substância com atividade inibidora de elastase leucocitária humana

Info

Publication number
BR0014831A
BR0014831A BR0014831-8A BR0014831A BR0014831A BR 0014831 A BR0014831 A BR 0014831A BR 0014831 A BR0014831 A BR 0014831A BR 0014831 A BR0014831 A BR 0014831A
Authority
BR
Brazil
Prior art keywords
substance
therapeutic drug
inhibitory activity
human leukocyte
leukocyte elastase
Prior art date
Application number
BR0014831-8A
Other languages
English (en)
Inventor
Shoji Takakura
Kyoko Minoura
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of BR0014831A publication Critical patent/BR0014831A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"DROGA TERAPêUTICA PARA LESõES REFRATáRIAS, COMPREENDENDO UMA SUBSTâNCIA COM ATIVIDADE INIBIDORA DE ELASTASE LEUCOCITáRIA HUMANA" A presente invenção provê uma droga terapêutica para lesões refratárias, compreendendo uma substância que possui atividade inibidora de elastase leucocitária humana como ingrediente eficaz.
BR0014831-8A 1999-10-12 2000-10-02 Droga terapêutica para lesões refratárias, compreendendo uma substância com atividade inibidora de elastase leucocitária humana BR0014831A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP28924799 1999-10-12
PCT/JP2000/006873 WO2001026685A1 (en) 1999-10-12 2000-10-02 Remedies for intractable wound

Publications (1)

Publication Number Publication Date
BR0014831A true BR0014831A (pt) 2002-08-27

Family

ID=17740693

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0014831-8A BR0014831A (pt) 1999-10-12 2000-10-02 Droga terapêutica para lesões refratárias, compreendendo uma substância com atividade inibidora de elastase leucocitária humana

Country Status (8)

Country Link
US (1) US20030207432A1 (pt)
EP (1) EP1230933A4 (pt)
KR (1) KR20020050235A (pt)
CN (1) CN1407902A (pt)
AU (1) AU7453700A (pt)
BR (1) BR0014831A (pt)
CA (1) CA2387199A1 (pt)
WO (1) WO2001026685A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL148924A (en) * 2002-03-26 2015-06-30 Mor Research Applic Ltd Use of substances that inhibit intracellular elastase activity in the preparation of a drug for the treatment and / or prevention of necrosis of cells and related diseases
WO2010020247A1 (en) * 2008-08-22 2010-02-25 Reapplix Aps Multilayered blood product
KR102431188B1 (ko) 2016-06-24 2022-08-10 포라 가세이 고교 가부시키가이샤 주름개선용 피부외용제
EP3711746A4 (en) * 2017-11-15 2021-08-25 Pola Chemical Industries Inc. OIL-BASED COMPOSITION

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0182906A1 (en) * 1984-06-14 1986-06-04 Cortech, Inc. Human leukocyte elastase inhibitors prepared from pyogenic bacteria and methods for their purification
PH27266A (en) * 1989-03-14 1993-05-04 Fujisawa Pharmaceutical Co WS7622, A,B,C and D substances and pharmaceutical composition containing same
US5232928A (en) * 1989-07-25 1993-08-03 Boehringer Ingelheim Pharmaceuticals, Inc. Tetrahydroisoquinoline amides
US5296591A (en) * 1990-12-31 1994-03-22 Fujisawa Pharmaceutical Co., Ltd. Trifluoromethylketone derivatives, processes for preparation thereof and use thereof
GB9115811D0 (en) * 1991-07-22 1991-09-04 Fujisawa Pharmaceutical Co Fr901451 substance,process for preparation thereof and use thereof

Also Published As

Publication number Publication date
EP1230933A1 (en) 2002-08-14
AU7453700A (en) 2001-04-23
CA2387199A1 (en) 2001-04-19
WO2001026685A1 (en) 2001-04-19
KR20020050235A (ko) 2002-06-26
CN1407902A (zh) 2003-04-02
US20030207432A1 (en) 2003-11-06
EP1230933A4 (en) 2004-01-02

Similar Documents

Publication Publication Date Title
AR025444A1 (es) Derivados de sulfonil-carboxamida, procedimientos para su preparacion y su utilizacion como medicamentos
AR026610A1 (es) Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central
NO20053150D0 (no) System for administrasjon av medisin.
BR0313733A (pt) Uso da proteìna n beta cinase
SV2003001107A (es) Imidazotriazinas ref.lea 35368
NO20053077D0 (no) Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer.
BR0312729A (pt) Novos derivados de indol-3-enxofre
BR0313676A (pt) Derivados de pirimidina e uso destes como moduladores cb2
BR0314918A (pt) Compostos de purina e uso dos mesmos como ligantes de receptor canabinóide
PT1401841E (pt) Derivados substituidos de 1-oxa-2,8-diaza-espiro[4.5]dec-2-eno como medicamentos para o tratamento da dor
AR027355A1 (es) Acidos tiazolidincarboxilicos
UY27455A1 (es) Derivados n-(1,4,5,6-tetrahidro-ciclopentapirazol -3-il)- sustituidos. su obtención y uso como fármacos.
PT1212312E (pt) Novos derivados de flavonas xantonas e cumarinas
BR0318278A (pt) compostos de éter aminocicloexìlico e usos dos mesmo
BR0315139A (pt) Agentes antibacterianos de tetraidroquinolina tricìclica
BRPI0410940A (pt) benzo[b]tiofenos substituìdos com cicloalquilsulfanila como agentes terapêuticos
BRPI0408889A (pt) uso de clusterina para o tratamento e/ou prevenção de doenças neurológicas periféricas
UY27451A1 (es) 2,5-diamidoindoles sustituidos y su utilización
IL178727A (en) Tetrahydropyridothiophene derivatives and pharmaceutical compositions containing the same
ECSP045405A (es) Penems 6-alquiliden heterotriciclil como inhibidores de la beta lactamasa
ATE326451T1 (de) Chinazolin derivate und therapeutische verwendungen davon
BR0014831A (pt) Droga terapêutica para lesões refratárias, compreendendo uma substância com atividade inibidora de elastase leucocitária humana
BRPI0509067A (pt) formulações de matriz oral que compreendem licarbazepina
AU2003227593A1 (en) New analogs of nitrobenzylthioinosine
HRP20080597T3 (en) Cancer combination therapy comprising azd2171 and zd1839

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]